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Exosomes are extracellular vesicles involved in intercellular communication. Bovine milk 
exosomes stability and their biological effects on macrophages have not been 
extensively investigated. Hence, the objectives of this study were to characterize bovine 
milk exosomes and investigate their effects on RAW 264.7 macrophages under 
normoxia and hypoxia. Bovine milk exosomes were isolated using differential 
centrifugation and identified by the presence of exosomal markers (ALIX, TSG101, and 
CD81) and particle size. The effect of in vitro digestion and pH on stability of milk 
exosomes was investigated. The biological activity of milk exosomes in RAW 264.7 
under normoxia was determined by measuring proliferation, expression of proliferation 
markers p53, p21, cyclin D1, CDK2 and β-catenin, cell cycle, and the protective effect of 
exosomes on cisplatin-induced cytotoxicity. The effect of exosomes on RAW 264.7 
under hypoxia was assessed by measuring proliferation, ROS production, cytokines, 
cell cycle, and the expression of hypoxia marker HIF-1α and proliferation markers p53 
and p21. Exosomes were positive for exosomal markers and their size was 106.8 nm ± 
3.4. Exosomal marker TSG101 was detected after digestion and exposure to different 
pH values. The treatment of exosomes significantly increased proliferation in cells under 
normoxia and had a protective effect against cisplatin-induced apoptosis. Proliferation 
markers were significantly affected by exosome treatment under normoxia. Cell cycle 
analysis in normoxia showed that exosome treatment reduced the percentage of pre-
apoptotic cells while arresting the cells in G2/M phase. Hypoxic conditions reduced the 
viability of cells by 27% while exosome treatment significantly increased the cell 
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viability. Generation of ROS under hypoxia was significantly reduced in the cells treated 
with exosomes. Hypoxia alone did not affect TNF-α, but exosome treatment significantly 
increased TNF-α in a dose-dependent manner under hypoxia. Cell cycle analysis 
showed that hypoxia alone arrested cells in the G0/G1 phase whereas exosome 
treatment reduced the percentage of cells in this phase. The results demonstrated that 
bovine milk exosomes isolated from commercially available milk are stable and affect 
macrophage proliferation under normoxia and hypoxia indicating the potential role of 
exosomes in the immune system. Further research is needed to understand milk 
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CHAPTER 1: INTRODUCTION AND LITERATURE REVIEW 
 
1.1 Literature review 
1.1.1 Exosomes 
Exosomes are extracellular vesicles involved in cell-to-cell communication 1. Initially, 
they were considered a waste product of the cells, but this common belief was 
dismissed in 1983 when two papers reported that small vesicles around 50nm in size 
were released from maturing blood reticulocytes 1,2. Since the discovery of exosomes 
released from reticulocytes, their secretion has been well documented in many types of 
cells and body fluids 3,4. It is important to mention that there are other types of 
extracellular vesicle including ectosomes and apoptotic bodies 5. Even though there is 
still some confusion about how to differentiate between different types of the 
extracellular vesicles, it is a well-accepted notion that exosomes originate from 
multivesicular bodies (MVB) while ectosomes originate from plasma membranes 6. 
Apoptotic bodies, on the other hand, are made during the processes of programmed-
cell death called apoptosis. The size among different types of extracellular vesicles is 
also another important characteristic that helps differentiate between them. Exosomes 
are considered to be smallest among them with the size from 50-150nm while 
ectosomes, also called microvesicles, size ranges from 50nm-1000nm 3. Apoptotic 
bodies are considerably larger ranging from 800-5000nm 7. Thus, the particle size 




1.1.2 Generation and release of exosomes 
As mentioned previously, exosomes originate from multivesicular bodies. One of the 
most commonly used definitions of generation of exosomes is that they are made by 
inward budding of endosomes 8. It starts with the formation of an early endosome which 
matures into a late endosome and formation of MVB. During this time, endosomal 
membrane invaginates to make intraluminal vesicles (ILV) that will be released as 
exosomes upon the endosome fusion with the cell surface 9. For the generation of ILVs 
and consequently exosomes, there are two mechanisms known: endosomal sorting 
complexes required for transport (ESCRT) dependent and ESCRT independent 10.  In 
the ESCRT dependent mechanism, the ESCRT complex is recruited to the endosome 
by transmembrane proteins that have been tagged with ubiquitin 5. It is important to 
mention that tumor susceptibility gene 101 (TSG101) is also capable of recognizing 
ubiquitin 5. Moreover, when TSG101 was knocked out, the secretion of exosomes was 
significantly impaired suggesting its importance in exosomes generation 11. In ESCRT 
independent mechanism, ESCRT complex is not required, and the formation of 
exosomes and sorting of exosomal cargoes is regulated by the members of tetraspanin 
family CD9, CD63 CD81 and CD82 3. Once exosomes are formed within MVB, the fate 
of MVB is to fuse with cell membrane and release exosomes out of cell or to fuse with 
lysosome and be degraded; however, little is known about this process 12. Once 
exosomes are released from the cell, the exosome uptake by other cells depends on 




1.1.3 Function and significance of exosomes 
Exosomes are small membranous vesicles with a major role in intercellular 
communication. In general, exosomes contain various proteins, lipids, and nucleic 
acids, and their content depends mostly on the type of cells they originate from 12. 
Lately, the presence and importance of exosomal RNAs have been extensively 
researched. Exosomes contain messenger RNA (mRNA) and micro RNA (miRNA) that 
can be transferred to the recipient cell and deliver new genetic information 14. By 
transferring new genetic information, the protein expression of the recipient cell may be 
altered. For instance, when human cells were incubated with mouse exosomes, distinct 
mouse proteins were identified in human cells suggesting that exosomal mRNA can be 
translated into proteins 15. Moreover, the transfer of exosomal RNA can differentially 
affect the gene expression in the recipient cells 16. With possessing the ability to alter 
the protein and gene expression, exosomes have been implicated in numerous 
physiological and pathological processes 17. For example, in a physiological condition, 
exosomes from dendritic cells may play an important role in activating immune system 
while in a pathological condition, exosomes released from cancer cells may exchange 
their oncogenic content with other cells 17. The function and therefore their significance 
are closely related to the type of cells that exosomes originate from.  
 
1.1.4 Exosomes isolation  
One of the most commonly used methods for isolation of exosomes is differential 
ultracentrifugation 4,18,19. Ultracentrifugation based method for exosomes isolation is 
considered to be the gold standard 20. Differential centrifugation isolation method utilizes 
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consecutive centrifugation steps with increasing speed and time. This method is based 
on the principle that larger particles settle down first leaving the smaller particles in the 
supernatant 21. Due to the size of exosomes and some size overlap with other 
molecules and extracellular vesicles, ultracentrifugation yields exosomes that may be 
contaminated 20. Ultracentrifugation can be accompanied by a density gradient which 
separates exosomes based on their size, mass, and density in a preconstructed density 
gradient medium 20. When exosomes are isolated based on density gradient using 
sucrose gradient medium, they float in densities from 1.15 to 1.19 g/ml 22.  
Another commonly used method of isolation of exosomes is size-based ultrafiltration 23. 
The main principle of ultrafiltration and ultracentrifugation is the same, separation based 
on the size. Using ultrafiltration, exosomes may be isolated based on molecular weight 
or their size 20. However, the ultrafiltration method utilizes force which may contribute to 
the loss of exosomes caused by rupturing their membranes 24.   
Exosomes precipitation is another technique used in isolation of exosomes and involves 
the use of polyethylene glycol (PEG) 25. The principle behind this method is that PEG 
binds water molecules making other compounds to precipitate. Moreover, commercially 
available kits such as ExoQuick (System Biosciences, United States) use PEG for 
exosome isolation 26. However, it is important to mention that this method has its 
disadvantages since other molecules such as protein can also precipitate making the 
exosome isolates contaminated 27.  
The presence of tetraspanins CD63, CD81, CD82, CD9 and ALIX among the other 
exosomal markers is the principle behind affinity-based isolation techniques 25. Even 
though affinity-based techniques can reduce isolation time and yield higher purity of 
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exosomes,  these techniques are expensive, inefficient and not recommended for 
isolation from large volumes 26.  
 
1.1.5 Detection and identification exosomes 
Commonly used methods for detection of exosomes are dynamic light scattering, flow 
cytometry and electron microscopy 28. However, dynamic light scattering favors larger 
molecules when in heterogenous solution while electron microscopy can alter the shape 
and size due to sample preparation steps 29. Both transmission electron microscopy and 
scanning electron microscopy have been used to detect exosomes 30. Regardless of the 
cell type, almost all exosomes are made by inward budding of endosomes; therefore, 
they contain proteins implicated in membrane transport and fusion (e.g., annexins, 
flotillins), biosynthesis of multivesicular body (e.g. ALIX and TSG101) and processes 
that require heat shock proteins integrins and tetraspanins (e.g. CD63, CD81) 31. Not 
surprisingly, the identification of exosomes has been heavily relying on the presence of 
these proteins 18,32. Western blot and ELISA are commonly used techniques for 
detection of exosomal proteins 28.  
 
1.1.6 Bovine milk exosomes  
Bovine milk is a nutrient rich-food that contains carbohydrates, lipids, proteins, minerals, 
and vitamins. Bovine milk and its compounds have been extensively researched over 
the years and their bioactivity have been well documented. Over the last 10 years, 
research related to bovine milk gained more interest since the discovery of exosomes. 
Earlier studies showed that microvesicles isolated from colostrum and mature milk were 
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approximately 100 nm in size with a distinct phospholipid bilayer membrane 33. In 
addition, the study reported that isolated exosomal RNA from colostrum and mature 
milk was translated into casein proteins suggesting that exosomal mRNA was intact 32. 
Interestingly, bovine milk exosomes may have been isolated in 1973 when a study 
found that bovine milk contains plasma membrane containing vesicles 34. However, 
researchers at the time started becoming aware of the difference between these 
vesicles and milk fat globule membranes (MFGM) 34,35 . Consequently, a study 
published in 2012 investigated the difference between MFGM proteome and exosome 
proteome 36. The study found that milk exosomes have different but also more diverse 
proteome compared to MFGM proteome 35. After establishing the procedure for isolation 
and characterization of exosomes, researchers investigated how Staphylococcus 
aureus mastitis affects exosome proteome 37. Interestingly, the study found that the 
infection changed protein expression of members of heat shock proteins, 
protocadherin gamma family and to some extent casein proteins. 
As the investigation on exosomes from the various cell was advancing and more 
information was known, consequently, research on bovine milk exosomes was 
advancing as well. In 2015, after transforming growth factor beta 1 (TGF-β1) was 
discovered on the surface of cancer exosomes 38, a study found that bovine milk 
exosomes are also enriched with TGF-β1 which can have immunoregulatory function 19. 
Moreover, a study published in 2017 found that bovine milk exosomes were enriched 
with proteins implicated in immune responses, while mature milk exosomes were 
enriched with proteins associated with transport and apoptosis suggesting that 
composition of exosomes changes as the milk matures 39.  
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1.1.7 Stability of milk exosomes 
As a potential food ingredient, the stability of milk exosomes across different food 
matrices is imperative. However, the stability of bovine milk exosomes has not been 
extensively investigated. In a study published in 2012, the researchers found that 
bovine milk contains mRNA and miRNA that are very stable against acidic conditions 
and RNAase treatment suggesting that these RNAs could resist manufacturing 
processing 40. Since miRNA and mRNA may be enclosed into exosomes and thus 
protected, another group of researchers was investigating whether exosomes would be 
stable against a wide range of conditions. Interestingly, when isolated from 
commercially available milk, exosomes were stable against low pH, boiling and multiple 
freeze-thaw cycles 19. However, when the study that was published later investigated 
whether the miRNA stability relies on the protection of exosomes, they concluded that 
stability of miRNA did not depend exclusively on exosomes but also other extracellular 
vesicles,  proteins or lipids 41. MiRNA is small, non-coding RNA that is able to regulate 
gene expression by binding to mRNA and preventing protein production 42. The 
importance of exosomal miRNAs and their implication in numerous pathological and 
physiological processes 43 is what lead researchers to investigate bioactivity of bovine 
milk exosomes.  
 
1.1.8 Biological activity of bovine milk exosomes  
Studies on the biological activities of bovine milk exosomes are limited but are gaining 
interest among researchers. Initial studies on biological activities focused on 
understanding if these bovine milk exosomes can be taken up by different cell types. In 
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2013, a study found that macrovesicles isolated from bovine colostrum were taken by 
RAW 264.7 cells 44. Moreover, the same study found that pretreatment with bovine milk 
vesicles affected the production of IL-1, IL-6, and IL-10 in LPS-treated RAW 264.7 cells 
suggesting that bovine milk exosomes have an immunomodulatory effect. Later in 2015, 
a study found that bovine milk exosomes can be taken by human macrophage cell line 
THP-1 45. Interestingly, the results demonstrated that only differentiated THP-1 cells 
were able to uptake bovine milk exosomes. Immunoregulatory properties of bovine milk 
exosomes isolated from commercially available milk were confirmed in another study 19. 
The study found that bovine milk exosomes contain transforming growth factor beta 
(TGF-β) on their surface and are able to differentiate naïve T-cells to T-helper 17 in 
vitro. The researchers suggested that the immunomodulatory effect of bovine milk 
exosomes on T-cell differentiation was associated with the presence of TGF-β.  
The confirmation that bovine milk exosomes are taken by RAW 264.7 cells came from 
the study published in 2015 46. Not only that bovine milk exosomes were taken up by 
RAW 264.7 cells, but also the pretreatment with bovine milk exosomes before LPS 
treatment, reduced the production of TNF-α and MCP-1 in adherent splenocytes 
indicating that bovine milk exosomes could have some anti-inflammatory properties 46. 
The bioactive properties of bovine milk exosomes were investigated in a recently 
published paper where in vitro, human colonic goblet LS174T cells showed an increase 
in mucus production when treated with bovine milk exosomes accompanied by 
increased goblet cell-associated gene expression of TFF3 32. In addition, in vivo, 
administration of bovine milk exosomes significantly increased the number of goblet cell 
in mice with necrotizing enterocolitis when compared to the untreated group and a 
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decrease of myeloperoxidase expression was seen in mice treated with bovine milk 
exosomes suggesting that bovine milk treatment prevented from the development of 
NEC 32. Even with a limited number of publications, there is evidence that bovine milk 
exosomes are biologically active, so a deeper understanding of their role in human 
health is imperative.  
 
1.1.9 Macrophages: cells of innate immunity 
Immune cells can broadly be divided into two categories: cells of innate immunity and 
cells of adaptive immunity. Macrophages, along with mast cells, dendritic cells, natural 
killer cells, eosinophils, basophils, and neutrophils are cells of innate immunity. 
Macrophages are primarily known to be professional phagocytes 47, but their function 
and role in the immune response are broader 48. Macrophages are motile cells 
containing various receptors on their surface that help them recognize a wide range of 
host and non-host ligands 47. Macrophages are not only able to engulf pathogenic 
organisms but also to remove debris and dying (apoptotic) cells 49,50.  
Different subpopulations of macrophages have been identified based on their function 
and location 51. According to some sources, macrophages can be divided into two 
groups: tissue-resident and monocyte-derived macrophages 52. It was believed that 
tissue-resident macrophages originate from monocytes; however, there was enough 
evidence that tissue macrophages originate from embryonic development rather than 
circulating monocytes 53. The function of tissue-resident macrophages is to engulf 
pathogens and to recruit other cells of immune system 51. In a resting state, 
macrophages that promote tissue repair are called M2 macrophages while 
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macrophages that sense a microbe become M1 macrophages 54. Polarization toward 
M1 or M2 macrophages also can be achieved by the presence of different cytokines. 
For instance, interferon gamma (IFN-γ) is a cytokine that promotes polarization of 
macrophages toward M1 phenotype while interleukin 4 (IL-4) is needed to polarize 
macrophages to M2 phenotype 55.  
As mentioned previously, macrophages have numerous receptors which they use to 
sense the environment around them 56. Receptors such as Toll-like receptors (TLR), 
Nod-like receptors (NLR) and scavengers are called pathogen receptors and are used 
to sense microbes. TLRs are membrane receptors used to sense bacterial, viral or 
fungal parts 56. NLRs are similar in their function to TLRs but they are located in the 
cytoplasm and can recognize damage-associated molecular patterns (DAMPs) 57. 
Scavenger receptors are membrane receptors and their function is to recognize 
bacterial parts or altered-self 56.  
One of the primary functions of macrophages is phagocytosis. When pathogen-
recognition receptors such as dectin-1 on macrophages recognize pathogen-associated 
molecular patterns, the process can initiate phagocytosis 58. Once the pathogen is 
internalized, the killing of pathogens is achieved when the phagosome fuses with a 
lysosome containing antimicrobial compounds 58. It is important to mention that one of 
the best-studied phagocytosis processes is one that is facilitated by immunoglobulins G 
(IgG) when Fcγ receptors on phagocytic cells recognize pathogens coated with IgG 59. 
Interestingly, even though phagocytosis was discovered more than 100 years ago, the 
process is not fully understood yet 59. Similarly to the pathogen recognition process, 
apoptotic bodies need to be recognized in order to be phagocytosed by macrophage 
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cells 58. Apoptotic bodies display molecules that are not normally present outside the 
cells and those molecules are recognized by the phagocytes.  
Another important function of macrophages is the secretion of numerous cytokines. 
Cytokines are small proteins released by cells with a role in cell-to-cell communication 
60. The most important function of cytokines is to regulate inflammation, and they can be 
divided into pro-inflammatory and anti-inflammatory cytokines 61.  Pro-inflammatory 
cytokines such as TNF-α, IL-1, and IL-6 are released after the cells sense the presence 
of pathogens via their receptors 61. The first cytokine to be released after the indication 
of immune responses is TNF-α 61. Although the function of TNF-α is complex, one of the 
major roles of this cytokine is the resistance to infections 62. IL-6 function is also 
complex including reduction of available iron seen in inflammation and differentiation of 
naïve CD4+ T cells 63. To this date, 11 members of IL-1 cytokine family have been 
identified and some of them have pro-inflammatory or anti-inflammatory properties 64. 
IL-1β, as a member of IL-1 cytokine family, is a proinflammatory cytokine and its 
secretion from the cell depends on the inflammasome formation 64.  
The function of anti-inflammatory cytokine is to lessen inflammation and prevent tissue 
damage from excess inflammatory response 65. One of the most potent anti-
inflammatory cytokines is IL-10 and its function is to inhibit the release of pro-
inflammatory cytokines 65. 
 
1.1.10 Cell cycle and cell proliferation  
Cell cycle and therefore cell proliferation is a tightly regulated process. The cell goes 
through phases gap 1 (G1), synthesis (S), gap 2 (G2) and finally mitosis (M) to produce 
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two daughter cells. G1 phase prepare cells for DNA synthesis which happens in S 
phase. Similarly, G2 phase prepares cells for mitosis which happens in the M phase of 
the cell cycle 66. This process is heavily controlled to prevent the division of cells if DNA 
is damaged. The cell has the ability to repair DNA damage; however, when DNA is too 
damaged to be repaired, the cell would initiate programmed cell death known as 
apoptosis 67. Development of cancer is followed by uncontrolled cell proliferation caused 
by the cell inability to induce apoptosis when damage is too large to be repaired 68. 
Factors involved in the cell cycle such as growth factors, oncogenes and anti-
oncogenes play a role in the ability of cells to undergo apoptosis 69. 
The central proteins that regulate the cell’s progression through different phases of the 
cell cycle are cyclin-dependent kinases (CDKs) 69. To become activated, CDKs need to 
be in the adequate phosphorylated state and in complex with cyclins 66. Moreover, to 
move to the next stage of the cell cycle, the cyclin from the previous stage needs to be 
degraded 66. However, tumor suppressor protein p53 can negatively regulate the cell 
cycle causing cell cycle arrest if DNA damage is present 70. Activation of p53 leads to 
activation of p21 which forms a complex with CDKs. The formation of a complex 
between p21 and CDK2 or CDK4 will inactivate CDKs thus preventing progression from 
G1 to S phase 71. One of the commonly used methods to analyze cell cycle is by flow 
cytometry using a fluorescence dye that binds DNA. The principle behind cell cycle 





Hypoxia is a phenomenon characterized by low oxygen concentrations that are not 
enough to maintain cellular function 73. In aerobic organisms, oxygen serves as the final 
electron acceptor in the process of adenosine triphosphate (ATP) formation during 
cellular respiration. The cells need a high constant ATP/ADP ratio to maintain normal 
function hence oxygen depletion lead to reduced cell viability 74. Cells sense hypoxia by 
different mechanisms and one of the ways is through mitochondria which is a primary 
site of oxygen consumption 75. It is important to say that hypoxia can be acute and 
chronic. While acute hypoxia can cause a disturbance in ion homeostasis, chronic 
hypoxia can alter gene expression 73. One of the first proteins that is activated in 
hypoxia is hypoxia-inducible factor family (HIF) which comprises of three different 
members HIF-1, HIF-2 and HIF-3 73. HIF-1 is the most ubiquitous and contains oxygen 
sensitive alpha (α) unit that is destabilized in the presence of oxygen 76. HIF-1α is 
degraded in normoxia, thus hypoxia stabilizes HIF-1α which can dimerize with HIF-1β. 
Once stabilized, HIF-1 can translocate into the nucleus and bind to targeted genes 
altering their expression 73,77. Hypoxia can play an important role in cell proliferation, 
differentiation, energy metabolism, acidosis, reactive oxygen species (ROS) formation 
and apoptosis 73. 
Swelling, heat, redness, and pain are four signs of inflammation. It is known that 
reduced oxygen concentrations are seen in inflamed tissue mostly due to pressure 
caused by swelling 78. Since hypoxia is associated with danger, the condition may result 
in macrophages polarizing to a pro-inflammatory phenotype 79. It is documented that the 
production of nitric oxide (NO) and TNF- α in macrophage cells is HIF-1α -dependent 80. 
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Also, a previous publish study demonstrated that hypoxia resulted in significant ROS 
generation and reduced cell viability in murine macrophage cell line RAW 264.7 81. ROS 
can damage DNA, proteins, and lipids but also have a beneficial effect in the cells of 
innate immunity since it is involved in the direct killing of pathogens 82. 
 
1.1.12 Macrophages and chemotherapeutic drugs  
Cancer is the second leading cause of death in the United States 83. Chemotherapeutic 
drugs are one of the available methods to treat cancer. The basic principle of 
chemotherapeutic drugs is that it targets the cells that are dividing. By doing that, 
chemotherapeutic drugs do not distinguish between healthy and cancer cell which can 
cause apoptosis in healthy cells. For instance, when RAW 264.7 cells were treated with 
doxorubicin, a chemotherapeutic drug, there was a significant decrease in cell viability. 
However, when RAW 264.7 cells were treated with doxorubicin and bacterial 
lipopolysaccharide (LPS), LPS prevented doxorubicin-induced apoptosis 84. Developing 
new drugs that will protect the healthy cell from killing while targeting cancer cells is still 
a challenge 85. 
 
1.2 Hypothesis and objectives 
Hypothesis of this study are: 
1. Exosomes are stable against in vitro digestion and changes in pH. 
2. Bovine milk exosomes will affect RAW 264.7 cells proliferation by affecting cell 
cycle. 
Objectives of this study are: 
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1. To isolate and characterize exosomes from commercially available bovine milk. 
2. To investigate the effect of bovine milk exosomes in RAW 264.7 cell under 
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2.1 Abstract 
Exosomes are extracellular vesicles involved in intercellular communication. The 
objectives were to characterize bovine milk exosomes and determine its effect on the 
proliferation of RAW 264.7 macrophages. Bovine milk exosomes were isolated using 
differential centrifugation and identified by the presence of exosomal markers (ALIX, 
TSG101, and CD81) and the particle size. The effect of in vitro simulated 
gastrointestinal digestion and different pH on stability of milk exosomes was 
investigated. The biological activity of milk exosomes in RAW 264.7 was conducted by 
measuring proliferation, expression of proliferation markers p53, p21, cyclin D1, CDK2 
and β-catenin and analysis of cell cycle. Moreover, the protective effect of exosomes on 
cisplatin-induced cytotoxicity in macrophages was investigated. Exosomes were 
positive on exosomal markers and their size was 106.8 nm ± 3.4. Exosomal marker 
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TSG101 was detected after digestion and exposure to different pH values. Proliferation 
markers were affected by exosome treatment. Cell cycle analysis showed that 
exosomes treatment reduced the percentage of pre-apoptotic cells while arresting the 
cells in G2/M phase. Exosomes had a protective effect against cisplatin-induced 
apoptosis in macrophages. The results demonstrated that bovine milk exosomes 
isolated from commercially available milk are stable and affected macrophage 
proliferation indicating its potential role in the immune system. Further research is 
needed to understand its role in human health.  
 
2.2 Introduction 
Bovine milk is a nutrient-rich food containing lipids, proteins, minerals, and vitamins that 
are needed for the growth and development of the calf. It contains immunoglobulins, 
hormones, growth factors, cytokines, enzymes and bioactive peptides 1. The 
immunoregulatory effect of bovine milk peptides in humans has been well documented 
2. An animal study suggests that oral administration of bovine lactoferrin and 
lactoperoxidase may attenuate pneumonia in mice infected with influenza virus 3. The 
results from multiple clinical trials suggest that bovine lactoferrin may reduce the 
incidence of sepsis in neonates 4. Furthermore, pretreatment with bovine milk may 
prevent acid and alcohol-induced gastric ulcer development in mice 5. Clearly, the 
consumption of milk has numerous potential benefits in human health. 
Exosomes are extracellular vesicle (30-120nm) and their synthesis and secretion have 
been documented in the most types of cell 6. Exosomal cargo heterogeneity depends on 
the type of the cell and may contain nucleic acids, enzymes, lipids and proteins 7.  
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Exosomes play an important role not only in cell-to-cell communication via transfer of 
the exosomal cargo from donor to recipient cell but also angiogenesis, cell survival, 
inflammation and immune response 8,9. 
Recently, food-sourced exosomes have been identified from different plants including 
ginger, carrots, grapefruit, and grape and they can alter the gene expression in the 
recipient cells 10. Moreover, isolation and identification of exosomes have been reported 
in human and commercially available bovine milk 11,12. Human milk exosomes are stable 
against in vitro digestion and are taken by human intestinal cells in vitro 11. In another 
study, oral administration of extracellular vesicles isolated from commercially available 
milk lessened arthritis in mice 12.  
Previous studies have revealed that bovine milk exosomes contain miRNA and 
messenger RNA 13,14. In the previously mentioned study, a very small difference in 
microRNA expression between exosomes isolated from raw and commercially available 
milk may suggest that heat treatment (pasteurization) does not affect exosome 
bioavailability 14. Micro-RNA has been implicated in numerous physiological and 
pathological processes including cancer 15. The US Centers for Disease Control and 
Prevention predicts that in the near future, cancer will be the leading cause of death in 
the United States. Chemotherapy is one of the available treatments for cancer; 
however, it does not distinguish between healthy and cancer cells. Protecting the 
heathy cells from the cytotoxic effect of chemotherapeutic drugs is still a major problem 
in cancer treatment 16.  
Bioactivity of bovine milk exosomes and their potential use as a functional food 
ingredient is still unknown. Therefore, the objective of this study was to isolate, 
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characterize and investigate the effect of pH and in vitro simulated gastrointestinal (GI) 
digestion on the stability of exosomes. Also, the biological activity of bovine milk 
exosomes and its effect on murine macrophage cell line RAW 264.7 with and without 
the chemotherapeutic drug cisplatin was investigated.  
 
2.3 Materials and methods 
2.3.1 Materials 
Murine macrophage RAW 264.7 cell line was purchased from American Type Culture 
Collection (Manassas, VA). Growth media DMEM 1X was purchased from Corning Inc. 
(Corning, NY). Fetal bovine serum (FBS) was purchased from Life Technologies 
(Carlsbad, CA). Primary antibodies (PDCD 61P (ALIX) 12422-1- AP, TSG 101 14497-1-
AP, CD81 18250-1-AP, CDK2 60312-1-Ig, β-catenin 51067-2-AP, p53 10442-1-AP, p21 
60214-1-Ig, cyclin D1 60186-1-Ig, and GAPDH 60004-1-Ig) were purchased from 
Proteintech (Rosemont, IL). Secondary antibodies (goat anti-mouse and goat anti-
rabbit) were purchased from Thermo Fisher Scientific (Waltham, MA). 
 
2.3.2 Isolation of exosomes 
Exosomes were isolated from commercially available fat-free milk (Great Value brand) 
by differential centrifugation under sterile conditions following previously described 
protocol with some modifications 17. Briefly, milk was centrifuged at 13,000 x g at 4 °C 
for 30 min in 250 mL centrifuge bottles using SS-34 rotor and SORVALL® RC-5B PLUS 
centrifuge. The whey was collected, transferred into polycarbonate 26.3 mL Beckman 
centrifuge tubes, and centrifuged at 100,000 x g at 4 °C for 60 min in Type 50.2 Ti rotor 
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using Optima XL-80K Ultracentrifuge (Beckman Coulter, Inc.). The final supernatant 
was collected, transferred to 26.3 mL centrifuge tubes and centrifuged at 135,000 x g at 
4 °C for 90 min. The supernatant was discarded, and the pellet was washed with PBS 
twice. The exosome pellet was collected and resuspended in PBS. Isolated exosomes 
were sterile filtered through 0.22 µm filters. The protein concentration of exosomes was 
adjusted to 6 mg/mL and stored at -80 °C until further use.  
 
2.3.3 Characterization of milk exosomes  
The protein concentration of exosomes was determined by Pierce TM BCA Protein Assay 
Kit (Thermo Scientific, Rockford, IL U.S.A). Exosomes were diluted to 1 mg/mL 
concentration for particle size and zeta potential analysis. The size and zeta potential 
were measured by Zetasizer (Malvern Instruments Ltd., Malvern, Worcestershire, UK). 
Protein profile of exosomes was assessed by SDS-PAGE and exosomal protein 
markers tumor susceptibility gene 101 (TSG101), cluster of differentiation 81 (CD81), 
and programmed cell death 6-interacting protein (PDCD 6IP-ALIX) were detected by 
western blot analysis described below.  
 
2.3.4 Effect of pH on exosomes stability 
Exosomes were diluted to 1 mg/mL concentration using PBS. Then, 10 mL of diluted 
exosomes was adjusted to different pH values (2, 3, 4, 5, 6, 8, 9, 10, 11, and 12) using 
hydrochloric acid (HCl) and sodium hydroxide (NaOH) accordingly. pH-adjusted 
samples were stirred at 550 rpm for 20 min at room temperature (RT). After stirring, the 
samples were centrifuged at 10,000 x g for 10 min at 4 °C. The supernatant was 
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collected, and the protein concentration of the supernatant was determined. The particle 
size and zeta potential of pH-adjusted samples were measured. Protein profile and the 
presence of exosomal markers TSG101, CD81 and ALIX was assessed by SDS-PAGE 
and western blot analysis, respectively.  
 
2.3.5 Pepsin-pancreatin digestion of exosomes  
Pepsin- pancreatin digestion was performed following previously reported procedure 18. 
Two milliliters of approximately 6 mg/mL exosomes were mixed with 8 mL PBS and the 
pH of the sample was adjusted to 2.0 using HCl. Pepsin was added at a 1:10 
enzyme:protein ratio. Pepsin digestion was carried out for 60 min in a shaking water 
bath at 37 °C.  To inactive pepsin, pH was adjusted to 7.5 using sodium hydroxide. A 5 
mL aliquot was taken and centrifuged at 10,000 x g for 10 min to remove any large 
particles. The supernatant was collected and used for further analysis. Pancreatin and 
bile were added to the remaining pepsin samples at a 1:10 enzyme: protein ratio, and 
the pancreatin digestion was carried out for 60 min in a shaking water bath at 37 °C. 
Pancreatin was inactivated by heating the samples at 75 °C for 20 min. Pancreatin 
samples were centrifuged at 10,000 x g for 10 min at 4 °C, and the supernatant was 
collected. Pepsin and pancreatin samples were analyzed for protein content, particle 
size, and zeta potential. Protein profile and the presence of TSG101, CD81, and ALIX 




2.3.6 SDS-PAGE and western blot detection of TSG 101, CD 81 and ALIX  
Isolated exosomes, pH-adjusted, and digested samples were mixed with an equal 
volume of 2x Laemmli sample buffer (Bio-Rad Laboratories, Inc.) containing 5% β-
mercaptoethanol and heated in boiling water for 5 minutes. An equal amount of protein 
(for pH-adjusted samples) and an equal volume (for digested samples) of samples were 
loaded into Mini-Protean ® TGXTM gel (Bio-Rad Laboratories, Inc.) and run in Bio-Rad 
Tris/Glycine/SDS buffer at 200 volts for 35 minutes. The gel was washed with deionized 
(DI) water 3 times (5 min each), and 50 mL of Bio-SafeTM Coomassie G-250 stain was 
added and gently shaken for 1 hour. The gel was rinsed with DI water for 30 min. For 
western blot analysis, after SDS-PAGE, the gel was equilibrated in blotting buffer for 15 
min. The proteins were transferred onto an AmershamTM HybondTM 0.45 µm 
polyvinylidene difluoride membrane (PVDF) at 110 volts for 60 min at 4 °C. The PVDF 
membrane was blocked with 5% non-fat dry milk in Tris-Buffered Saline -0.01% Tween 
20 (TBST) for 1 h at room temperature. After blocking, the membrane was washed in 
TBST three times each time for 5 min. The membrane was incubated with primary 
antibodies against TSG101, CD81 and ALIX (Proteintech Group, Inc. IL, USA) at 1:1000 
dilution overnight at 4 °C. After washing, secondary anti-rabbit antibodies at 1:5000 
dilutions were incubated for 1.5 h at room temperature. The membrane was washed, 
saturated with Bio-Rad ClarityTM Western ECL Substrate and imaged by a C-Digit blot 




2.3.7 Cell culture and cell proliferation assay 
Murine macrophages RAW 264.7 were cultured in DMEM containing 10% fetal bovine 
serum and 1% penicillin/streptomycin and at 37 ºC in 5% CO2 until confluency. Briefly, 2 
X 105 cells/well were seeded into a 6-well plate in the total volume adjusted to 2 mL and 
incubated overnight to attach at 37 ºC in 5% CO2. After overnight incubation, the cells 
were treated with different exosomes concentration ranging from 30 to 250 µg/mL for 24 
h. The cells were harvested according to the protocol described below. For proliferation 
assay, 5 X 103 cells/well were seeded into a 96-well plate in the total volume 200 µL and 
incubated overnight to attach at 37 °C in 5% CO2. Then, the cells were treated with 
different exosomes concentration (15 to 250 µg/mL) with or without cisplatin (5 µM) for 
24h. After the treatment, the growth media was replaced with 100 µL fresh plain growth 
media containing 10% MTS reagent and incubated for 3 h under the same conditions as 
described above. The absorbance was read at 490 nm and the percent of viable cells 
was calculated with respect to untreated cells.  
 
2.3.8 Whole cell lysate preparation 
After the cells were treated, 6-well plates were placed on ice and the growth media was 
removed. The cells were washed twice with ice-cold PBS to remove cell debris. After 
washing, 100 µL radioimmunoprecipitation assay (RIPA) lysis buffer containing 1% 
protease inhibitor complex was added to each well and incubated for 5 min. Cells were 
harvested by scraping and transferred to 1.5 mL microfuge tubes and vortexed at 14, 
000 x g for 10 minutes at 4 °C. The supernatant was collected, and protein 
concentration was measured using Bradford reagent and BSA as the standard. The 
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supernatant was mixed with Laemmli buffer containing 5% β-mercaptoethanol in equal 
volumes and boiled for 5 min. The samples were stored at -80 °C until use.  
 
2.3.9 Western blot for proliferation proteins p21, p53, β-catenin, cyclin D1 and 
CDK 2 
Approximately, 10 µg of the protein of the cell lysate was loaded in 8-16% SurePAGE 
(GenScript) gels. The gel electrophoresis was run in Tris-MOPS-SDS (GenScript) 
running buffer at 140 volts for 50 min. Proteins were transferred into the Trans-Blot® 
TurboTM  PVDF membrane (Bio-Rad) using Trans-Blot®TurboTM Transfer System (Bio-
Rad). After the transfer, the membrane was blocked with 5% non-fat dry milk in TBST 
for 1 h at room temperature. After blocking, the membrane was washed in TBST three 
times each time for 5 min. The membrane was incubated with primary antibodies 
against cyclin-dependent kinase inhibitor 1 (p21), cyclin-dependent kinase 2 (CDK 2) 
and β-catenin at dilution 1:1000, tumor protein (p53) at dilution 1:3000, and cyclin D1 
and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) at dilution 1:5000 overnight 
at 4 °C. After incubation, the membrane was washed as described above and 
secondary antibodies (anti-rabbit for p53 and β-catenin and anti-mouse for p21, cyclin 
D, CDK 2 and GAPDH) at dilution 1:5000 were incubated for 1.5 h at room temperature. 
Finally, the membrane was washed, saturated with Bio-Rad ClarityTM Western ECL 




2.3.10 Cell-cycle analysis by flow cytometry  
The cells were fixed and stained following the previously described protocol 19. Briefly, 
the cells were seeded in 6-well plates and treated with exosomes (60 and 250 µg/mL) 
and with cisplatin and exosomes (60 µg/mL) following above described protocol. After 
treatment, the plates were placed on ice, and the media was removed. The cells were 
washed with ice-cold PBS twice. Two hundred µL of growth media was added to each 
well and the cells were scraped. Additional 800 µL of growth media was added to each 
well and cells were transferred to 1.5 mL microfuge tubes. The cells were centrifuged at 
1000 x g for 5 min at 4 °C. After centrifugation, the supernatant was removed, and the 
cells were resuspended in 60 μL PBS. Then, 70% ethanol was added to the cell 
suspension drop by drop with constant vortexing. The cells were left overnight at 4 °C 
for fixation. After fixation, cells were centrifuged at 300 x g at room temperature, the 
supernatant was removed and 1 mL staining mixture containing propidium iodide and 
RNase was added. The cells were vortexed and incubated for 1 h at 37 °C protected 
from light. Cell cycle analysis was performed using MACSQuant flow cytometer and 
data analyzed with MACSQuantify software (Miltenyi Biotec, Somerville MA). 
 
2.3.11 Statistical analysis   
All experiments were performed in at least three independent replicates. All results are 
expressed as mean±SD or mean±SEM. Analysis of variance (ANOVA) with Tukey’s test 
was done to determine a significant difference (p<0.05) between different treatment 




2.4 Results and discussion 
2.4.1 Characterization and identification of bovine milk exosomes from 
commercially available milk  
Bovine milk exosomes were isolated from commercially available milk using differential 
centrifugation technique. Milk exosomes were characterized by particles size 
distribution and surface zeta potential by dynamic light scattering. Fig 2.1A ( all figures 
are located in the appendix) shows the average particle size of bovine exosomes was 
106.8nm ± 3.427 with a polydispersity index (PDI) of 0.227 ± 0.019 consistent with 
previously reported values 17. The average zeta potential was -9.88mV ±- 0.706 (Fig 
2.1B). Zeta potential is one of the important parameters that influence nanoparticle 
stability 20. Zeta potential in this range suggests short time particle stability while zeta 
potential in the range from -5 mV to +5 mV would indicate a fast aggregation 20.  
For further characterization and identification, exosome lysates were prepared and 
analyzed using western blot for the presence of exosomal markers. As shown in Fig 
2.1C, milk exosomes were positive for ALIX, TSG101, and CD81. Despite the cell type, 
almost all exosomes have endosomal origin; therefore, they contain proteins implicated 
in membrane transport and fusion (e.g., annexins, flotillins), biosynthesis of 
multivesicular body (e.g. ALIX and TSG101) and processes that require heat shock 
proteins integrins and tetraspanins (e.g. CD63, CD 81) 6. Consequently, exosomes 
identification has been relying heavily on the presence of exosomal proteins such as 




2.4.2 Bovine milk exosomes are stable against pH changes  
The effect of pH on milk exosomes has not been studied well. There is a limited number 
of research that have been done on the exosome’s stability and quality as affected by 
different pH. As a potential functional food ingredient, the stability of milk exosomes 
over a range of pH is of crucial importance for food application. As seen in Fig 2.2A, 
exosomes solubility is dependent on the pH of the solution. At pH 4, milk exosomes are 
the least soluble. The isoelectric point of milk casein is 4.6 which may suggest that 
some proteins may be present in the exosome’s solution and precipitate at pH close to 
isoelectric point of casein. Proteins are least soluble around and at isoelectric point, and 
as pH changes away from the isoelectric point, protein solubility increases. Bovine milk 
exosomes are most soluble at pH 7.4 which is close to milk pH. In a previously 
published letter, the results showed that when exosomes were exposed to pH 4 and pH 
10, exosomes concentration decreased 22. Further, Fig 2.2B shows that particle size of 
exosomes is also dependent on the pH of the solution. The particle size of exosomes is 
smallest at pH 5 (91.96nm ± 4.267) but the most uniform particle size is at pH 4 with 
PDI of 0.093±0.017. This would confirm that larger particles precipitate at pH 4 point 
leaving in the solution smaller particles with similar size including exosomes. Largest 
PDI (0.305 ± 0.01) is at pH 6 showing that different size populations are present at this 
pH condition and it may suggest that at this point, the solution would not be stable. Zeta 
potential is an important parameter that influences the stability of nanoparticles. In Fig 
2.2C, it can be seen that surface zeta potential is also dependent on solution pH. As pH 
decrease, zeta potential increase and vice versa. This can be explained that proteins at 
lower pH are protonated making the surface more positively charged 23. Zeta potential 
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reaches zero value at pH between 3 and 4. At this value, exosomes are least soluble, 
and the solution would not be stable. Exosomal protein TSG101 was detected in all 
different pH exosome solutions (Fig 2.2D). At these protein concentrations, ALIX and 
CD 81 were not detected (not shown). A reduction in TSG101 signal can be seen at pH 
12. Clearly, extremely high pH values decrease exosomes quantity which is consistent 
with reported results 22. However, even though soluble protein concentration at pH 12 
remains almost not changed when compared to exosomes at pH 7.4, TSG101 
concentration decrease. This suggests that proteins other than exosomal marker 
TSG101 may be present in isolated exosomes and these proteins are highly soluble at 
higher pH.  
 
2.4.3 Bovine milk exosomes resist pepsin-pancreatin hydrolysis  
The application of milk exosomes as a potential functional food ingredient depends on 
the ability of exosomes to survive human digestion and to reach intestines and 
circulation in an intact form. Exosome size slightly increased (123.2nm ± 3.394) after 
subjecting exosomes to pepsin like-conditions with a wider particle size range (Fig 
2.3A). Moreover, particle size decreased (113.5nm ± 0.167) when pepsin-digested 
exosomes were subjected to pancreatin part of digestion, but still, the particle size was 
larger than the size of non-digested exosomes (Fig 2.3A). This may be explained by 
structural changes in exosomes exposed to simulated pepsin digestion. However, after 
pepsin-pancreatin hydrolysis, the particle size range was narrower suggesting that 
some large particles have been partially hydrolyzed at this point. The protein 
concentration of pepsin and pancreatin like solution remained unaffected (data are not 
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shown). The effect of in vitro digestion on milk exosomes stability has not been 
extensively researched. Recently, the results of a study suggested that milk exosomes 
isolation was not affected by subjecting milk to in vitro digestion prior to the isolation and 
there was no difference in exosomes size, morphology and miRNA content when 
compared to exosomes isolated from undigested milk 24. Moreover, the same study 
found that milk exosomes were able to pass human intestinal epithelium in vitro using 
Caco-2 cell culture suggesting that milk exosomes may be able to reach the blood 
circulation.  
Pepsin-pancreatin hydrolysis did not affect zeta potential. However, this may be 
explained by non-significant changes in solution pH. After digesting exosomes with 
pepsin at pH 2, pepsin digestion was stopped with adjusting pH to neutral conditions 
(~7.5). Pepsin-pancreatin digestion was performed at the same neutral pH condition 
with no change in zeta potential suggesting that the pH of solution is one of the 
important factors that influences zeta potential. Pepsin-pancreatin digestion did reduce 
the signal of exosomal markers (Fig 2.3C). After the pepsin digestion, TSG101 and 
CD81 were detected with CD81 signal being lower than that one of TSG 101. 
Furthermore, after pepsin-pancreatin digestion, only TSG101 was detected. Clearly, 
there was a reduction in TSG101 signal when compared to the non-digested and 
pepsin-digested samples. The presence of TSG101 suggests that exosomes survive in 
vitro digestion.  
Following in vitro digestion and effect of pH, exosome proteins profile was investigated 
by SDS-PAGE (Fig 2.3D). The most apparent bands and reduction of the same bands 
in hydrolyzed and exosomes exposed to low pH are seen between 25 kDa and 37kDa 
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which corresponds to the molecular weight of casein proteins 25. Also, a slight reduction 
at pH 2, pH 3 and pH 4can be seen at 75kDa band. In the previous study of human milk 
exosomes, bands in this range were suggested to be related to protein lactoferrin which 
is also abundant in bovine milk and has been found to have antibacterial, 
immunomodulatory and anti-cancer activity 11,26. Even though there is a reduction in the 
appearance of some bands, clearly some proteins are still present even after complete 
pepsin-pancreatin digestion suggesting that exosomes are resistant to simulated 
digestive conditions.  
 
2.4.4 Bovine milk exosomes affect proliferation and have a protective effect on 
cisplatin treated RAW 264.7 cells 
Macrophages are cells of the immune system involved in the first line of defense during 
infection 27. In Fig 2.4A, treatment with bovine milk exosomes increases proliferation of 
RAW 264.7 cells in a dose-dependent manner. Treatment with 15, 30, and 60 μg/mL 
bovine exosomes significantly increased proliferation when compared to untreated 
macrophages. At 250 µg/mL, macrophage proliferation was significantly increased by 
49.7% when compared to untreated cells. Interestingly, the proliferation of RAW 264.7 
was not accompanied by activation of the cells since nitric oxide, and proinflammatory 
cytokines (e.g. TNF-α, IL-6) were not produced (data not shown). The effect of different 
compounds on inflammatory responses and activation of RAW 264.7 have been widely 
researched. Mostly, these research papers focus on compounds that are capable of 
activating RAW 264.7 while inducing nitric oxide and cytokine production (pro-
inflammatory) or alleviating inflammatory responses (anti-inflammatory)28,29. Our results 
43 
 
showed for the first time that food-derived compounds, such as bovine milk exosomes, 
can influence macrophage proliferation. 
Further, when cells were co-treated with exosomes and cisplatin (5 μM), treatment with 
exosomes increases macrophage cell survival indicating a protective effect of bovine 
milk exosomes against cisplatin-induced cytotoxicity as shown in Fig 2.4B. At a 
concentration of 250 μg/mL exosomes, the cell survival of 95.3% was significantly 
increased when compared to the survival of 81.2% when cells were treated with 
cisplatin only. The proliferation of macrophages as well as the potential cytotoxic effect 
of chemotherapeutic drugs such as cisplatin is not well studied. Cisplatin is a 
chemotherapeutic drug that binds to DNA and prevents its repair causing cells to go to 
apoptosis 30. However, cisplatin, as majority of other chemotherapeutic drugs, is not a 
selective agent meaning it does not distinguish between healthy and cancer cells. 
Protective effect of bovine milk exosomes may contribute to a better understanding of 
how to protect normal cells from the cytotoxic effect of chemotherapeutic drugs.  
 
2.4.5 Bovine milk exosomes affect proliferation markers (proteins) in RAW 264. 7 
cells 
Proliferation markers such as p21 and p53  play an important role not only in cell 
proliferation and cell cycle but also in the immune response in macrophage cells 31,32. 
Fig 2.5 shows a dose-dependent effect of bovine milk exosomes treatment on 
proliferation markers in RAW 264.7 cells. In our study, exosomes treatment with 60 and 
250 μg/mL significantly increased β-catenin expression by 42.5% and 40.8%, 
respectively, when compared to untreated macrophages. β-catenin is a protein involved 
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in multiple functions including development, tissue homeostasis, cell renewal, adhesion 
and cell signaling 33. Recently, the role of β-catenin in infections and immune cells was 
investigated. In a couple of studies, the role of β-catenin in the immune system cells 
susceptibility to different bacterial and viral agents was investigated 34,35. In the above-
mentioned study, overexpression of β-catenin in Pseudomonas aeruginosa infected 
RAW 264.7 cells promoted bacterial elimination with no effect on NO and ROS 
production 34. In addition, investigators found that an increased level of β-catenin in 
monocytes when compared to monocyte-derived macrophages suppressed HIV 
replication suggesting that β-catenin plays an in important role in HIV replication 35.  
Bovine milk exosomes increased p53 expression in RAW 264.7 in a dose-dependent 
manner with 250 μg/mL exosome treatment significantly increasing p53 expression by 
2-fold when compared to negative control. The p53 protein has a vital role in cell 
proliferation by repairing DNA and inducing apoptosis when DNA damage is too serious 
to be repaired 36. Also, a frequent p53 mutation in cancer cells makes this protein as a 
potential target in normal cells that would prevent them from the killing effect of 
chemotherapeutic drugs 16. Increased expression of p53 protects normal cells from the 
cytotoxic effect of chemotherapeutic drugs 16 is consistent with our observation that 
bovine milk exosomes protected macrophages against cisplatin-induced cytotoxicity. 
Moreover, in one study, transient overexpression of p53 in RAW 264.7 significantly 
reduced Listeria monocytogenes invasion when compared to control cells. In vivo 
results from the same study confirmed that knocking out p53 expression accelerated 
and increased lethality in mice 32.  
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Bovine milk exosomes also significantly affected p21 expression (Fig 2.5). At a 
concentration of 250 μg/mL, p21 expression was significantly increased by 66.8%. p21 
is transcriptionally regulated by p53 and it has numerous functions in the cell cycle and 
apoptosis. For instance, overexpression of p21 in several cell type can protect cells 
from apoptosis 37. Also, in a previous study, the role of p21 in LPS-stimulated peritoneal 
macrophage was investigated and the results showed that deletion of p21 was 
accompanied by an increase in the production of pro-inflammatory cytokines TNF-α and 
IL-1β 31. While CDK-2 expression levels in RAW 264. 7 cells were not significantly 
affected by exosomes treatment (p=0.08), cyclin D1 expression was significantly 
affected. It can be seen that bovine milk exosomes treatment reduced the expression of 
cyclin D1 in a dose-dependent manner where treatment with 60 µg/mL and 250 µg/mL 
reduced the expression by 36.2% and 51.8% respectively when compared to untreated 
cells. Cyclin D1 is one of the regulators of the cell cycle progression from G1 to S phase 
and its quick degradation is required for cells to move from G1 to S phase 38. Also, in a 
previous study, the results showed that Bac1.2F5 macrophages treated with IFN-γ 
showed an increased level of cyclin D1 resulting in blocking macrophage proliferation 39. 
A decrease in the expression of cyclin D1 upon treatment of exosomes may play an 
important role in the proliferation of macrophages making cells progress to the next 




2.4.6 Milk bovine exosomes affect the cell cycle of RAW 264.7 with and without 
cisplatin 
Fig 2.6 shows the effect of bovine milk exosomes on RAW 264.7 proliferation cell cycle 
with or without cisplatin treatment. Exosomes treatment affected the proliferation of the 
cells in a dose-dependent manner. In the absence of cisplatin (Fig 2.6A), the number of 
apoptotic cells when macrophages were treated with exosomes was significantly 
reduced by 37.9% and 53.35% when cell treated with 60µg/mL and 250 μg/mL 
respectively although there was no significant difference between the two exosomes 
concentrations. Also, the reduction of cells by 10.7% can be seen in the G0/G1 phase of 
the cell cycle when cells are treated with 250 µg/mL exosomes. The exosomes 
treatment arrest cells in S and G2/M phase. In the S phase, 250 µg/mL exosomes 
treatment increased the number of cells by 16.0%, while in G2/M phase the cell number 
increased by 47.9%. To our knowledge, there have been only very few research 
conducted on RAW 264.7 cell cycle. One of the papers was investigating how 
Salmonella infection affects the cell cycle in RAW 264.7 40. In a study of the effect of 
riboflavin deprivation in RAW 264.7, when cells were deprived of riboflavin, the results 
showed a decrease in the S and G2/M phase 41. On the other hand, another study 
reported that cypermethrin treatment increased the percentage of the cells in G1; 
therefore, inducing death by arresting cells in this phase 42. Our results indicate that an 
increase in proliferation is accompanied by an increase in S and G2/M phase.  
When RAW 264.7 cells were treated with exosomes and cisplatin (5 µM), exosomes 
treatment (60 µg/mL) reduced the number of pre-apoptotic cells by 17.4% when 
compared to the cells treated with cisplatin only (Fig 2.6B). Cisplatin treatment arrests 
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the cells in pre-apoptotic phase. Moreover, exosomes treatment in the presence of 
cisplatin reduced the number of cells in the G0/G1 phase by 35.9% when compared to 
the cells treated with cisplatin only. Arrest in G2/M phase was seen in the cells treated 
with exosomes and cisplatin with an increase in the number of cells by 28.5%.  
 
2.5 Conclusion 
Our study found that commercially available milk exosomes resist in vitro digestion and 
pH change. Moreover, this is the first report on how bovine milk exosomes affected 
proliferation of macrophages, an important component of our immune system. Bovine 
milk exosomes also protected macrophages against cisplatin-induced cytotoxicity by 
affecting the expression of proteins involved in cell cycle and proliferation. Further 
research is needed to better understand the role of bovine milk exosomes and their 
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Figure 2.1. Characterization of milk exosomes by particle size distribution (A) and zeta 
potential (B). Identification of milk exosomes by western blot analysis on exosomal 


































































Figure 2.2. Stability of exosomes at different pH values presented as solubility of milk 
exosome proteins over a range of pH values (A), particle size distribution with PDI (B), 
surface zeta potential (C) and detection of exosomal protein TSG101 (D). Results are 
























































































Figure 2.3. Effect of simulated pepsin-pancreatin digestion on size (A), and zeta 
potential of milk exosomes (B), the presence of exosmal proteins ALIX, TSG101 and 
CD81 (C), and the effect of pH and pepsin-pancreatin hydrolysis on the protein profile 














































































Figure 2.3 continued. Effect of simulated pepsin-pancreatin digestion on size (A), and 
zeta potential of milk exosomes (B), the presence of exosmal proteins ALIX, TSG101 
and CD81 (C), and the effect of pH and pepsin-pancreatin hydrolysis on the protein 

































Figure 2.4. Effect of milk exosomes on RAW 264.7 proliferation without (A) and with 
cisplatin (B). Results are presented as mean ± SD. Means that do not share a letter are 
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Figure 2.5. Effect of milk exosomes on RAW 264.7 expression of proliferation proteins 
β- catenin, p53, p21, CDK2 and cyclin D1 (A). Western blot on proliferation markers β- 
catenin, p53, p21, CDK2 and cyclin D1. GAPDH shown present housekeeping protein 
(B). Results are presented as mean ± SE (A). Means that do not share a letter are 



















































































Figure 2.6. Cell-cycle of RAW 264.7 cell treated with bovine milk exosomes without (A) 
and with cisplatin (B). Results are presented as mean ± SD (A). Means that do not 


































































CHAPTER 3: THE EFFECT OF BOVINE MILK EXOSOMES ON THE 






















Exosomes are extracellular vesicles implicated in cell-to-cell communication and their 
secretion has been documented in almost all types of cells. The objective of this study 
was to isolate exosomes from commercially available milk and investigate its effect in 
RAW 264.7 cells under hypoxia. Exosomes were isolated from commercially available 
skim milk using differential centrifugation and their presence was identified by particle 
size and exosomal markers TSG101, CD81, and ALIX. The effect of bovine milk 
exosomes on RAW 264.7 cells under hypoxia was investigated by assessing 
proliferation, cytokine and ROS production, and cell cycle. Moreover, the hypoxia 
marker HIF-1α and proliferation markers p53 and p21 were assessed by western blot. 
The average size of exosomes was 152.2 nm ± 4.25 measured by dynamic light 
scattering method. Exosomes treatment increased the cell viability under hypoxia when 
compared to untreated cells. ROS production was significantly reduced with exosomes 
treatment (p<0.05). The production of TNF-α was not affected by hypoxia alone but 
increased in a dose-dependent manner in cells treated with exosomes under hypoxic 
condition. Hypoxia arrested cells in the G0/G1 phase whereas exosome treatment 
reduced the cell in this phase. However, there was no effect on the expression of HIF-
1α, p53, and p21. Our study found that bovine milk exosomes affect the proliferation of 






Hypoxia is a condition that is characterized by low oxygen concentrations caused by the 
low blood supply to the body’s tissue. Not all forms of hypoxia are deleterious to body 
tissue. In some cells and tissue, such as intestinal epithelial cells, low oxygen 
concentrations are considered physiological, hence the term physiological hypoxia 1. 
However, when an environment of low oxygen causes the impaired function of the cells 
and tissues, hypoxia can become pathological. Often, the reduction of blood supply and 
consequent low oxygen concentrations can be seen in the inflamed and injured tissue. 
This is due to the inability of blood vesicles to grow and supply oxygen to the growing 
affected tissue caused by infiltration of the cells 2. Consequently, hypoxia may cause 
immune cell impairment and dysfunction.  
Macrophages are the cells of the innate immune system and their primary function is 
phagocytosis. They exist in our body in two different forms: tissue-resident and 
monocyte-derived macrophages 3. When a pathogen gets sensed, one of the functions 
of the tissue-resident macrophage is to start initiating inflammatory response 4. In an 
environment of low oxygen tension, which is often seen in inflammation, macrophages 
upregulate some genes in order to perform their function in hypoxic environment. 
Hypoxia-inducible factor family is one of the genes that is upregulated in low oxygen 
conditions and upregulation of HIF-1α is implicated in hypoxia-induced apoptosis 5,6. 
Furthermore, when macrophage cells were infected with Escherichia coli and 
Staphylococcus aureus and exposed to hypoxic conditions, the ability of macrophages 
to eliminate these two pathogens was significantly reduced even though these 
pathogens are readily killed by macrophages under normoxic conditions 7. 
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Consequently, hypoxia and its effect on the cells of the immune system have been 
extensively investigated and alternative ways such as the application of bioactive food 
compounds in lessening the effects of hypoxia have been a novel approach.  
Exosomes are extracellular vesicles with sizes ranging from 50-150nm 8. Their 
synthesis and secretion have been well documented in almost all types of cells 9. Lately, 
the presence and isolation of exosomes from different foods including milk and edible 
plants and their effect on human health have been investigated 10,11. It has been 
documented that bovine milk exosomes contain miRNAs that are resistant to in vitro 
digestion and are taken up by the human macrophage cell line THP-1 12,13. Moreover, in 
a recently published study, bovine milk exosome treatment prevented the development 
of necrotizing enterocolitis in vivo 14.  
The effect of food derived exosomes on hypoxia-induced changes has not been 
extensively investigated. Moreover, a recently published study found that bovine milk 
exosomes increased the proliferation of intestinal epithelial cells in vitro under hypoxia 
15. Therefore, the objective of this study was to isolate bovine milk exosomes from 
commercially available milk and investigate its effect on the proliferation of murine-like 
macrophages RAW 264.7 under hypoxic conditions.  
 
3.3 Materials and methods  
3.3.1 Materials 
Murine macrophage RAW 264.7 cell line was purchased from American Type Culture 
Collection (Manassas, VA). Growth media DMEM 1X was purchased from Corning Inc. 
(Corning, NY). Fetal bovine serum (FBS) was purchased from Life Technologies 
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(Carlsbad, CA). Primary antibodies (p53 10442-1-AP, p21 60214-1-Ig, HIF-1α 20960-1-
AP, and GAPDH 60004-1-Ig) were purchased from Proteintech (Rosemont, IL). 
Secondary antibodies (goat anti-mouse and goat anti-rabbit) were purchased from 
Thermo Fisher Scientific (Waltham, MA). 
 
3.3.2 Isolation and characterization of bovine milk exosomes and particle size 
analysis 
Exosomes were isolated from commercially available fat-free milk by differential 
centrifugation under sterile conditions following previously described protocol with some 
modifications16. Briefly, milk was centrifuged at 13,000 x g at 4 °C for 30 min in 250-mL 
centrifuge bottles using SS-34 rotor and SORVALL® RC-5B PLUS centrifuge. The whey 
was collected, transferred into polycarbonate 26.3-mL Beckman centrifuge tubes, and 
centrifuged at 100,000 x g at 4 °C for 60 min in Type 50.2 Ti rotor using Optima XL-80K 
Ultracentrifuge (Beckman Coulter, Inc.). The final supernatant was collected, transferred 
to 26.3-mL centrifuge tubes and centrifuged at 135,000 x g at 4 °C for 90 min. The 
supernatant was discarded, and the pellet was washed with PBS twice. The exosome 
pellet was collected and resuspended in PBS. The protein concentration of exosomes 
was determined by Pierce TM BCA Protein Assay Kit (Thermo Scientific, Rockford, IL 
U.S.A). Exosomes were diluted to 1 mg/mL concentration for particle size and zeta 
potential analysis. The size and zeta potential were measured by Zetasizer (Malvern 
Instruments Ltd., Malvern, Worcestershire, UK). Exosomal marker TSG101, CD81, and 
ALIX were determined by western blot. Isolated exosomes were sterile filtered through 
0.22 µm filters and stored at -80 °C until further use.  
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3.3.3 Cell culture and cell proliferation assay 
Murine macrophages RAW 264.7 were cultured in DMEM containing 10% fetal bovine 
serum and 1% penicillin/streptomycin and at 37 ºC in 5% CO2  until confluency. For 
proliferation assay, 5 X 103 cells/well were seeded into a 96-well plate in the total 
volume of 200 µL and incubated overnight to attach at 37 °C in 5% CO2. Then, the cells 
were treated with different exosomes concentration (0, 100 and 200 µg/mL) and placed 
in a hypoxia chamber for 24 h. The composition of the gas in the hypoxia chamber was 
94% N2, 5% CO2 and 1% O2. Untreated cells were incubated under normoxia. After the 
treatment, the growth media was replaced with 100 µL fresh plain growth media 
containing 10% MTS (Promesa, Madison WI) reagent and incubated for 3 h under 
normoxia. The absorbance was read at 490 nm and the percent of viable cells was 
calculated with respect to untreated cells under normoxia.  
 
3.3.4 Whole cell lysate preparation and supernatant collection 
Briefly, 2 X 105 cells/well were seeded into a 6-well plate in the total volume adjusted to 
2 mL and incubated overnight to attach at 37 ºC in 5% CO2. After overnight incubation, 
the cells were treated with 0, 100 and 200 μg/mL exosomes and placed in a hypoxia 
chamber containing 94% N2, 5% CO2 and 1% O2 for 24h. Untreated cells were 
incubated under normoxia. After 24h of treatment, the 6-well plates were placed on ice 
and the growth media was collected for cytokine analysis. The cells were washed twice 
with ice-cold PBS to remove cell debris. After washing, 100 µL radioimmunoprecipitation 
assay (RIPA) lysis buffer containing 1% protease inhibitor complex was added to each 
well and incubated for 5 min. Cells were harvested by scraping and transferred to 1.5 
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mL microfuge tubes and vortexed at 14, 000 x g for 10 min at 4 °C. The supernatant 
was collected, and protein concentration was measured using Bradford reagent and 
BSA as the standard. The supernatant was mixed with Laemmli buffer containing 5% β-
mercaptoethanol in equal volumes and boiled for 5 min. The samples were stored in -80 
°C until use. 
  
3.3.5 Production of ROS by flow cytometry 
Briefly, RAW 264.7 cells were seeded, treated and incubated in the 6-well plates under 
normoxia and hypoxia following the above-mentioned protocol. After treatment, the 
plates were placed on ice and the media was removed. The cells were washed with ice-
cold PBS twice. Two hundred µL of growth media was added to each well and the cells 
were scraped. Additional 800 µL of growth media was added to each well and cells 
were transferred to 1.5 mL microfuge tubes. The cells were centrifuged at 1,000 x g for 
5 min at 4 °C. After centrifugation, the supernatant was removed, and the cells were 
resuspended in 1 mL PBS. The cells were again centrifuged at 1,000 x g for 5 min at 4 
°C and supernatant was removed. Finally, the cells were resuspended in 500 μL PBS 
containing 10 μM 2’,7’-dichlorofluorescein diacetate and incubated at 37 °C for 30 min in 
a CO2 incubator. The number of cells with green fluorescence was measured using the 
FL 1 channel of a MACSQuant flow cytometer and data was analyzed with 




3.3.6 Enzyme-linked immunosorbent assay (ELISA) for measurement cytokine 
production (IL-1β, IL-6, IL-10 and TNF-α) 
Production of IL-1β, IL-6, IL-10 and TNF-α was measured using commercially available 
ELISA kits (BioLegend, San Diego CA). The cytokine detection was performed using 
the supernatant collected after the cell treatment with exosomes. Briefly, uncoated 
plates were incubated with capture antibodies overnight at 4 °C. After incubation, the 
plates were washed with washing buffer 4 times and blocked with assay diluent for 1 h 
with shaking at room temperature. After blocking, the plates were washed, and 
standards and samples were plated and incubated with shaking at room temperature for 
2 h. The plates were washed after the sample incubation and detection antibodies were 
added and incubated for 1 h with shaking after which the plates were washed and the 
avidin-HRP solution was added and incubated for 30 min with shaking. Finally, after 
washing, the substrate solution was added and incubated in the dark for 15 or 20 min. 
The stop solution was added, and absorbance was read at 450 nm. The concentration 
of cytokines was calculated based on the standard curve for each cytokine. 
 
3.3.7 Western blot for hypoxia marker HIF-1α and proliferation proteins p21 and 
p53 
Approximately, the 10 µg of proteins of the cell lysate was loaded in 8-16% SurePAGE 
(GenScript) gels. The gel electrophoresis was run in Tris-MOPS-SDS (GenScript) 
running buffer at 140 volts for 50 min. Proteins were transferred into the Trans-Blot® 
TurboTM  PVDF membrane (Bio-Rad) using Trans-Blot®TurboTM Transfer System (Bio-
Rad). After the transfer, the membrane was blocked with 5% non-fat dry milk in TBST 
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for 1 h at room temperature. After blocking, the membrane was washed in TBST three 
times for 5 min each. The membrane was incubated with primary antibodies against 
cyclin-dependent kinase inhibitor 1 (p21) at dilution 1:1000, tumor protein (p53) at 
dilution 1:3000, hypoxia-inducible factor-1α (HIF-1α) at 1:1000 dilution and 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (house-keeping protein; for 
normalization of data) at dilution 1:5000 overnight at 4 °C. After incubation, the 
membrane was washed as described above and secondary antibodies (anti-rabbit for 
p53 and HIF-1α and anti-mouse for p21 and GAPDH) at dilution 1:5000 were incubated 
for 1.5 h at room temperature. Finally, the membrane was washed, saturated with Bio-
Rad ClarityTM Western ECL Substrate and imaged by a C-Digit blot scanner (Li-Cor 
Biosciences, U.S.). 
 
3.3.8 Cell-cycle analysis by flow cytometry  
The cells were fixed and stained following the previously described protocol 17. Briefly, 
the cells were seeded in 6-well plates and treated with exosomes (0, 100 and 200 
µg/mL) under hypoxia following above-described conditions. Also, untreated cells were 
incubated under normoxia. After treatment, the plates were placed on ice and the media 
was removed. The cells were washed with ice-cold PBS twice. Two hundred µL of 
growth media was added to each well and the cells were scraped. Additional 800 µL of 
growth media was added to each well and cells were transferred to 1.5 mL microfuge 
tubes. The cells were centrifuged at 1,000 x g for 5 min at 4 °C. After centrifugation, the 
supernatant was removed, and the cells were resuspended in 60 μL PBS. Then, 70% 
ethanol was added to the cell suspension drop by drop with constant vortexing. The 
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cells were left overnight at 4 °C for fixation. After fixation, cells were centrifuged at 300 x 
g at room temperature, the supernatant was removed and 1 mL staining mixture 
containing propidium iodide and RNase was added. The cells were vortexed and 
incubated for 1 h at 37 °C protected from light. Cell cycle analysis was performed using 
MACSQuant flow cytometer and data analyzed with MACSQuantify software (Miltenyi 
Biotec, Somerville MA). 
 
3.3.9 Statistical analysis   
All experiments were performed in at least three independent replicates. All results were 
expressed as mean±SD or mean±SEM. Analysis of variance (ANOVA) with Tukey’s test 
was done to determine a significant difference (p<0.05) between different treatment 
groups using Minitab statistical software (Minitab Inc., Pennsylvania, USA) 
 
3.4 Results and discussion  
3.4.1 Identification of bovine milk exosomes isolated from commercially available 
milk using particle size 
Bovine milk exosomes were isolated from commercially available milk. The particle size 
distribution was measured using a dynamic light scattering method. As shown in Fig 
3.1, the average particle size of milk exosomes was 152.2 nm ± 4.25 which is consistant 
with the literature 18. Polydispersity index (PDI) was 0.289 ± 0.024. In the previously 
mentioned article, the size of bovine milk exosomes depends on the maturation stage of 
milk 18. Mature milk has a larger particle size distribution when compared with 
exosomes isolated from colostrum. In addition, the amount of exosomal miRNA isolated 
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from commercially available milk did not significantly differ from the amount of exosomal 
miRNA from raw milk suggesting that standard heat treatment does not affect 
exosomes 10. The average zeta potential of bovine milk exosomes was -10.9 mV ± 
0.834 which would suggest short-term stability. Furthermore, the stability of exosomes 
also depends on storage conditions, pH and thaw-freeze cycles 19. Consequently, the 
refrigeration temperatures are not recommended for long-term storage and can reduce 
exosomal proteins and RNA 20. Bovine milk exosomes isolated from commercially 
available milk were positive for exosomal markers ALIX, TSG101 and CD81 (Fig 3.2). 
The identification of exosomes has been relying on the presence of ALIX, TSG101 and 
CD81 16.   
 
3.4.2 Bovine milk exosomes increased the proliferation of RAW 264.7 cell under 
hypoxia  
Macrophages are fast acting phagocytic cells of innate immune system 21. In Fig 3.3, 
exosomes treatment significantly increased the proliferation of RAW 264.7 cells when 
compared to untreated cells under hypoxia. The cell viability decreased by 27% when 
untreated cells were incubated under hypoxia compared to untreated cells incubated 
under normal oxygen conditions. Moreover, exosomes treatment at 100 and 200 µg/mL 
significantly increased the cells proliferation by 27.9% and 32.6%, respectively. The 
results showed that exosomes treatment reversed the anti-proliferative effect of hypoxia 
in macrophages and macrophage proliferation when treated with exosomes under 
hypoxia is the same as proliferation of macrophages in normoxia. The macrophage cells 
exist in two states: tissue-resident and monocyte-derived macrophages 3. Since they 
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are the cells of innate immunity, they are the first line of defense when an infection 
happens. Often, in the case of inflamed and damaged tissue, the levels of oxygen may 
decrease which may cause a decrease in macrophage function and finally apoptosis 22. 
Decreased function or apoptosis can lead to a reduced ability of macrophages to fight 
an infection. Furthermore, to our knowledge, this is the first report on the effect of 
bovine milk exosomes on RAW 264.7 cell proliferation under hypoxia. In a recently 
published article, bovine milk exosomes and yak milk exosomes increased the cell 
survival of mouse small intestine epithelial cells (IEC-6) under hypoxia conditions 15. 
Moreover, in the same article, both yak and bovine milk exosomes were taken up by 
IEC-6 in both normoxic and hypoxic conditions.  
 
3.4.3 Bovine milk exosomes reduced production of ROS in RAW 264.7 cell under 
hypoxic conditions 
Reactive oxygen species are generated under oxidative stress. The oxidative stress 
may be defined as an imbalance between free radicals and antioxidants 23. In our study, 
hypoxia caused a significant 4- fold ROS reduction in untreated cells when compared to 
the untreated cell under normoxic conditions (Figure 3.4). Furthermore, the exosome 
treatment significantly reduced the ROS production when compared to untreated cells in 
hypoxic conditions. However, there was no significant difference in ROS production 
between the cell treated with 100 µg/mL and 200 µg/mL exosomes. It is still 
controversial whether hypoxic conditions increase ROS production. Our findings are not 
consistent with current literature 24,25. For instance, when RAW 264.7 cells were 
incubated in hypoxic conditions (1% O2) for 20 h, there was a significant increase in 
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ROS production when compared to the cell incubated in normoxic conditions 24 and 
when RAW 264.7 cells were grown under hypoxia (0.5% O2) for 10 h, there was a 
significant increase in ROS production when compared to the cells grown under 
normoxia 25. Consequently, differences in exposure time and oxygen concentrations 
may have affected the production of ROS.  
Cellular hypoxia is more defined as a state of reductive stress where reducing 
equivalents such as NADH and FADH2 build up if oxygen is not available 23. Moreover, 
the buildup of reducing equivalents makes the electrons more available to reduce the 
available oxygen to superoxide. However, even if reducing equivalents are available, 
the formation of ROS is not possible when oxygen is not present 26. It was reported that 
the formation of ROS depends on constant cycles of anoxia and reoxygenation 26. 
Another study repeated that reoxygenation increased the formation of ROS in RAW 
264.7 cell with fast reoxygenation producing more ROS when compared to slow 
reoxygenation 24. In our study, we have seen a decrease in ROS when the cells were 
exposed to hypoxia and it may be due to exposing the cells to hypoxia for a longer 
period of time where no more available oxygen was present to produce ROS. Moreover, 
ROS are very short-living molecules with unpaired electrons that are transformed and 
eliminated in the variety of cellular processes 27. The reduction in ROS generation in our 
study may be explained by possible transformation or elimination of ROS over a 




3.4.4 Bovine milk exosomes increased TNF-α in RAW 264.7 under hypoxia 
Production of TNF-α was increased in the cells treated with exosomes under hypoxia in 
a dose-dependent manner (Fig 3.5). When the cells were treated with 100 µg/mL and 
200 µg/mL exosomes, the concentration of TNF-α was 90.8 pg/mL and 172.4 pg/mL 
respectively. However, there was no significant difference in the TNF-α concentration 
between untreated cell under hypoxia when compared to the untreated cell under 
normoxia. Clearly, hypoxia itself was not enough to affect TNF-α production in RAW 
264.7 cells which is consistent with the literature where TNF-α was not induced in RAW 
264.7 cells in hypoxic conditions even after 48 h 28. TNF-α is a proinflammatory cytokine 
that plays an important role in host defense against pathogens 29. Previously published 
study found that the treatment with human TNF-α increased the resistance against 
Listeria infection in in vivo mouse model 30. Immunomodulatory effect of bovine milk 
exosomes in RAW 264.7 cells under hypoxia that was observed in our study may have 
a beneficial effect in fighting an infection in a low oxygen environment. IL-1β, IL-6, and 
IL-10 were not affected by hypoxia and exosome treatment. 
 
3.4.5 Bovine milk exosomes did not affect the expression of HIF-1α, p21 and p53 
As shown in Fig 3.6, HIF-1α, p21, and p53 were not affected by hypoxia or exosomes 
treatment under hypoxia. Although a low oxygen environment is considered to be on the 
most important factors of HIF-1α expressions, there is evidence that prolonged hypoxia 
may decrease expression of HIF-1α 31. In the previously mentioned study, when the 
human lung adenocarcinoma cells (A549) were exposed to 0.5%O2 for 12 h, HIF-1α 
expression significantly decreased when compared to the expressions at the exposure 
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time of 4 h. The expression of p21 is regulated by p53 32, so it is not surprising that both 
proteins were not affected.  
 
3.4.6 Bovine milk exosomes affect the cell cycle of RAW 264.7 cells under 
hypoxia 
The cell cycle of RAW 264.7 cells under hypoxia and the effect of bovine milk exosomes 
on the cell cycle can be seen in Fig 3.6. Our results showed that exposing RAW 264. 7 
cells to hypoxia caused cell arrest in the G0/G1 phase of the cell cycle when compared 
to the cell under normoxia. The percent number of cells in G0/G1 phase significantly 
decreased from 61.3% in untreated cells under hypoxia to 56.7% and 56.9% in the cell 
treated with 100 μg/mL and 200 μg/mL exosomes, respectively. There was no 
significant difference (p< 0.05) between untreated cells under normoxia and the cells 
treated with exosomes under hypoxia suggesting that bovine exosomes treatment is 
capable of reversing the effect of hypoxia on cell cycle of RAW 264.7 cell. The number 
of cells in pre-apoptotic phase did not significantly differ between different treatments. A 
significant reduction of cells in the S phase can be seen in untreated cells exposed to 
the hypoxic condition when compared to the cells exposed to normoxic conditions. 
Moreover, when the cells were treated with 100 μg/mL and 200 μg/mL exosomes, the 
percent of untreated cells under hypoxia in S phase increased from 10.9% to 15.5% and 
16.9%, respectively, which was not statistically different from the number of untreated 
cells under normoxia in S phase. It is well documented that exposing the cells to a low 
oxygen environment affects the cell cycle progression. Not many studies have been 
done on the effect of hypoxia on RAW 264.7 cell. One of the previously published 
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articles found that exposing  RAW 264.7 cells to hypoxia increased the number of 
apoptotic cells in 24 h 33. While our study did not find any difference in the number of 
apoptotic cells, the arrest in G0/G1 and reduction of cells in S phase was consistent 
with the current literature 34. To our knowledge, this is the first study that investigates 
the effect of bovine milk exosomes on the cell cycle progression in RAW 264.7 cells 
under hypoxia. Clearly, bovine milk exosomes were able to reverse the effect of hypoxia 
on the cell cycle of RAW 264.7 cells.  
 
3.5 Conclusion 
Our study found that bovine milk exosomes are present in commercially available 
bovine milk suggesting that the pasteurization process does not destroy them. Their 
bioactivity was investigated in RAW 264.7 cells subjected to hypoxia, and we found that 
bovine milk exosomes can reverse adverse effects caused in a case of low oxygen 
supply which can be seen in damaged or inflamed tissue. Further investigation on a 
deeper understanding by which mechanism bovine milk exosomes reverse the effect of 
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Figure 3.3. Proliferation of RAW 264.7 cell treated with bovine milk exosomes under 
hypoxia. Results are presented as mean ± SD. Means that do not share a letter are 





Figure 3.4. Relative production of reactive oxygen production (ROS) in RAW 264.7 cell 
treated with bovine milk exosomes under hypoxia. Results are presented as mean ± 
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Figure 3.5. TNF-α production in RAW 264.7 cells treated with bovine milk exosomes. 
Results are presented as mean ± SD. Means that do not share a letter are significantly 




Figure 3.6. Effect of milk exosomes on RAW 264.7 expression of hypoxia protein HIF-
1α and proliferation proteins p53 and p21. Results are presented as mean ± SE. Means 







































































            0           0 100    200 μg/mL exosomes 
            -           +   +      + hypoxia 
          0              0           100           200 μg/mL exosomes 





Figure 3.7. The effect of hypoxia and bovine milk treatment on the cell cycle of RAW 
264.7 cells. Results are presented as mean ± SD. Means that do not share a letter are 
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CHAPTER 4: CONCLUSION AND FUTURE WORK 
 
It has been well-documented that the consumption of bovine milk has multiple benefits 
on human health. Recently, the discovery of exosomes and their presence in bovine 
milk contributed to a better understanding of how milk affects human health. Our study 
found that exosomes are present in commercially available milk suggesting that 
pasteurization temperatures do not destroy their integrity. The presence of exosomes 
after pasteurization process suggests that consuming heat-treated may not affect their 
biological activity but also this may be important for the potential application in the food 
industry. Also, our results supported the previously published findings that bovine milk 
exosomes are stable and can resist in vitro digestion suggesting that bovine milk 
exosomes may reach small intestines and therefore be absorbed in an intact form. 
Bovine milk exosomes increased the proliferation and protect RAW 264.7 cells from 
cisplatin-induced apoptosis in normoxia. Moreover, bovine milk exosome treatment 
significantly increased cells proliferation and had an immunomodulatory effect under 
hypoxia. Our results suggest that bovine milk exosomes could have a beneficial effect 
on human health so further research is needed to understand their biological activity.  
Bovine milk exosomes have not been extensively studied so there is still a lot unknown 
about the topic. Clearly, for any further research, isolation of bovine milk exosomes 
needs to be improved. Our study demonstrated that differential centrifugation along with 
filtration was not enough to remove all residual milk proteins. Application of pH or 




As a bioactive milk component, the stability of milk exosomes over time, and how the 
storage time affects their bioactivity and uptake should be investigated. To our 
knowledge, no study has been published on the effect of storage condition and time on 
the stability of bovine milk exosomes. Also, we demonstrated that bovine milk 
exosomes resisted in vitro digestion so the next step would be to investigate their 
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